#BMSatAACR

Behind the Science of Immuno-Oncology

 

Discover Bristol Myers Squibb’s commitment to advancing Immuno-Oncology through research.

Behind the Science of Immuno-Oncology
D

iscover Bristol Myers Squibb’s commitment to advancing Immuno-Oncology through research into new pathways and biomarkers.


 Innovation in Immuno-Oncology Research
Innovation in Immuno-Oncology Research
Read an overview of cancer and the immune system.
Understanding Immuno-Oncology Pathways 
Read more about our exploration into immune system pathways and the role they play in cancer growth.
wowerpoint
Commitment to Translational Medicine
Read more about our translational medicine research, which helps further our understanding of cancer biology and answer key clinical questions in Immuno-Oncology.
II-ON
The International Immuno-Oncology Network (II-ON)

Launched in 2012 by Bristol Myers Squibb, the II-ON was one of the first networks to bring academia and industry together to further the scientific understanding of Immuno-Oncology. 

Media Contacts

We can assist you with media requests - just ask.